Clinical Efficacy of Nalmefene for Chronic Type Ⅱ Respiratory Failure / 中国药房
China Pharmacy
;
(12)1991.
Article
in Chinese
| WPRIM
| ID: wpr-533521
ABSTRACT
OBJECTIVE:
To study the clinical efficacy of Nalmefene in the treatment of chronic type Ⅱrespiratory failure.METHODS:
A total of 40 patients with chronic type Ⅱ respiratory failure were randomly divided into treatment group and the control group the treatment group received Nalmefene (1.0 mg) plus 5% GS (250 mL) q.d by iv gtt. in addition to the routine treatment, and the control group received 1.875 g Nikethamide plus 5% GS (250 mL) q.d by iv gtt. After 5-day treatment, the clinical symptom, physical signs, adverse drug reactions, lung function testing and blood gas analysis in two groups were evaluated.RESULTS:
The overall response rate was 95.0% in the treatment group vs. 60.0% in the control group(P
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
China Pharmacy
Year:
1991
Type:
Article
Similar
MEDLINE
...
LILACS
LIS